rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2010-9-23
|
pubmed:abstractText |
To explore whether adjuvant treatment options may impact on the prognosis in localized endometrial stromal sarcomas (ESSs; stages I and II). The historical options usually discussed in addition to hysterectomy and bilateral salpingoophorectomy (BSO) are active surveillance, pelvic radiotherapy, chemotherapy and hormonal therapy, alone or in combination.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1569-8041
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2102-6
|
pubmed:meshHeading |
pubmed-meshheading:20305035-Adult,
pubmed-meshheading:20305035-Aged,
pubmed-meshheading:20305035-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20305035-Brachytherapy,
pubmed-meshheading:20305035-Chemotherapy, Adjuvant,
pubmed-meshheading:20305035-Combined Modality Therapy,
pubmed-meshheading:20305035-Endometrial Neoplasms,
pubmed-meshheading:20305035-Female,
pubmed-meshheading:20305035-Follow-Up Studies,
pubmed-meshheading:20305035-Humans,
pubmed-meshheading:20305035-Hysterectomy,
pubmed-meshheading:20305035-Middle Aged,
pubmed-meshheading:20305035-Neoplasm Recurrence, Local,
pubmed-meshheading:20305035-Neoplasm Staging,
pubmed-meshheading:20305035-Pelvic Neoplasms,
pubmed-meshheading:20305035-Prognosis,
pubmed-meshheading:20305035-Radiotherapy, Adjuvant,
pubmed-meshheading:20305035-Retrospective Studies,
pubmed-meshheading:20305035-Sarcoma, Endometrial Stromal,
pubmed-meshheading:20305035-Survival Rate
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.
|
pubmed:affiliation |
Department of Medicine, Institut Gustave-Roussy, 39 rue Camille Desmoulins, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|